Cancer Cell Metabolism: One Hallmark, Many Faces

Cancer cells must rewire cellular metabolism to satisfy the demands of growth and proliferation. Although many of the metabolic alterations are largely similar to those in normal proliferating cells, they are aberrantly driven in cancer by a combination of genetic lesions and nongenetic factors such...

Full description

Bibliographic Details
Main Authors: Cantor, Jason R. (Author), Sabatini, David (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Whitehead Institute for Biomedical Research (Contributor), Koch Institute for Integrative Cancer Research at MIT (Contributor), Sabatini, David M. (Contributor)
Format: Article
Language:English
Published: American Association for Cancer Research, 2015-04-23T15:17:35Z.
Subjects:
Online Access:Get fulltext
LEADER 02092 am a22002173u 4500
001 96736
042 |a dc 
100 1 0 |a Cantor, Jason R.  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Biology  |e contributor 
100 1 0 |a Whitehead Institute for Biomedical Research  |e contributor 
100 1 0 |a Koch Institute for Integrative Cancer Research at MIT  |e contributor 
100 1 0 |a Sabatini, David M.  |e contributor 
700 1 0 |a Sabatini, David  |e author 
245 0 0 |a Cancer Cell Metabolism: One Hallmark, Many Faces 
260 |b American Association for Cancer Research,   |c 2015-04-23T15:17:35Z. 
856 |z Get fulltext  |u http://hdl.handle.net/1721.1/96736 
520 |a Cancer cells must rewire cellular metabolism to satisfy the demands of growth and proliferation. Although many of the metabolic alterations are largely similar to those in normal proliferating cells, they are aberrantly driven in cancer by a combination of genetic lesions and nongenetic factors such as the tumor microenvironment. However, a single model of altered tumor metabolism does not describe the sum of metabolic changes that can support cell growth. Instead, the diversity of such changes within the metabolic program of a cancer cell can dictate by what means proliferative rewiring is driven, and can also impart heterogeneity in the metabolic dependencies of the cell. A better understanding of this heterogeneity may enable the development and optimization of therapeutic strategies that target tumor metabolism. Significance: Altered tumor metabolism is now a generally regarded hallmark of cancer. Nevertheless, the recognition of metabolic heterogeneity in cancer is becoming clearer as a result of advancements in several tools used to interrogate metabolic rewiring and dependencies. Deciphering this context-dependent heterogeneity will supplement our current understanding of tumor metabolism and may yield promising therapeutic and diagnostic utilities. 
520 |a National Institutes of Health (U.S.) (Grant CA129105) 
546 |a en_US 
655 7 |a Article 
773 |t Cancer Discovery